Form 4: GeneDx Holdings CFO Sells Shares
Insider Transaction (Form 4)
Kevin Feeley, CHIEF FINANCIAL OFFICER of GeneDx Holdings Corp., sold 3,728 shares of common stock on September 16, 2026.
Summary
- Option exercise/conversion: acquired 7,197 Class A Common Stock on September 16, 2026; holds 48,673 after (Direct).
- Open-market sale: disposed of 586 Class A Common Stock at $94.26 ($55,235) on September 16, 2026; holds 48,087 after (Direct).
- Open-market sale: disposed of 52 Class A Common Stock at $95.41 ($4,961) on September 16, 2026; holds 48,035 after (Direct).
- Open-market sale: disposed of 541 Class A Common Stock at $96.90 ($52,423) on September 16, 2026; holds 47,494 after (Direct).
- Open-market sale: disposed of 1,470 Class A Common Stock at $98.27 ($144,457) on September 16, 2026; holds 46,024 after (Direct).
- Open-market sale: disposed of 1,079 Class A Common Stock at $99.00 ($106,816) on September 16, 2026; holds 44,945 after (Direct).
- Option exercise/conversion: disposed of 7,197 Restricted Stock Unit on September 16, 2026; holds 14,393 after (Direct).
Sentiment
Score: 4
Explanation: StockSavvy.ai views this as a mildly negative signal: an insider sold $363,892 of stock on the open market.
Insider Transactions
Kevin Feeley — Officer (CHIEF FINANCIAL OFFICER)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-09-16 | Option exercise/conversion | Class A Common Stock | 7,197 | — | — | 48,673 |
| 2026-09-16 | Open-market sale | Class A Common Stock | 586 | $94 | $55.2K | 48,087 |
| 2026-09-16 | Open-market sale | Class A Common Stock | 52 | $95 | $5.0K | 48,035 |
| 2026-09-16 | Open-market sale | Class A Common Stock | 541 | $97 | $52.4K | 47,494 |
| 2026-09-16 | Open-market sale | Class A Common Stock | 1,470 | $98 | $144.5K | 46,024 |
| 2026-09-16 | Open-market sale | Class A Common Stock | 1,079 | $99 | $106.8K | 44,945 |
| 2026-09-16 | Option exercise/conversion | Restricted Stock Unit | 7,197 | — | — | 14,393 |
Key Dates
| Date | Description |
|---|---|
| 2026-09-16 | Option exercise/conversion (7,197 shares) |
| 2026-09-16 | Open-market sale (586 shares) |
| 2026-09-16 | Open-market sale (52 shares) |
| 2026-09-16 | Open-market sale (541 shares) |
| 2026-09-16 | Open-market sale (1,470 shares) |
| 2026-09-16 | Open-market sale (1,079 shares) |
| 2026-09-16 | Option exercise/conversion (7,197 shares) |
Keywords
insider transaction, Form 4, WGS, GeneDx Holdings Corp., bearish, Kevin Feeley
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.